Scarica l'app Stockscreener
11.05
0.09%
-0.010
Dopo l'orario di chiusura:
11.10
0.05
+0.45%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AUPH Giù?
Forum
Previsione
Frazionamento azionario
Aurinia Pharmaceuticals Inc Borsa (AUPH) Ultime notizie
Will earnings trigger a reversal in Aurinia Pharmaceuticals Inc.Market Trend Review & Smart Investment Allocation Insights - newser.com
Can Aurinia Pharmaceuticals Inc. (IKAP) stock reach $200 price targetJuly 2025 Trends & Free Real-Time Market Sentiment Alerts - newser.com
Aurinia Defends Benefit/Risk Profile of Lupus Nephritis Treatment After FDA Official's Retracted LinkedIn Post - MarketScreener
What analysts say about Aurinia Pharmaceuticals Inc stockEconomic Impact on Stocks & Double Digit Profit Strategies - earlytimes.in
Aurinia Pharma rises after defending lupus drug - TradingView
Aurinia Sinks After FDA Official Questions Its Drug in Post - Bloomberg.com
Aurinia responds after top FDA official’s comment on lead drug - Seeking Alpha
Aurinia Pharma Stands By Lupus Drug After FDA Official’s Retracted Post Sparks 16% Selloff — Retail Stays Bullish On Recovery - MSN
How Aurinia Pharmaceuticals Inc. (IKAP) stock compares with top peersQuarterly Portfolio Report & Proven Capital Preservation Methods - newser.com
Can swing trading help recover from Aurinia Pharmaceuticals Inc. lossesMarket Volume Report & Weekly High Return Forecasts - newser.com
Aurinia Pharmaceuticals stock hits 52-week high at 13.45 USD By Investing.com - Investing.com Nigeria
Aurinia Responds to Now Retracted LinkedIn Post - Business Wire
Why retail investors pile into Aurinia Pharmaceuticals Inc. stockWeekly Trade Analysis & Low Volatility Stock Recommendations - newser.com
Pharma company Aurinia falls after FDA official uses LinkedIn to call out lupus drug - Sherwood News
Aurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 52-Week HighHere's Why - MarketBeat
Aurinia drops after FDA official criticizes voclosporin - TipRanks
Aurinia Sinks After FDA Official Questions Its Drug on LinkedIn - Bloomberg.com
Pattern recognition hints at Aurinia Pharmaceuticals Inc. upside2025 Earnings Surprises & Fast Moving Market Watchlists - newser.com
Using AI based signals to follow Aurinia Pharmaceuticals Inc.Exit Point & Intraday High Probability Setup Alerts - newser.com
Smart tools for monitoring Aurinia Pharmaceuticals Inc.’s price actionJuly 2025 News Drivers & Weekly Breakout Opportunity Watchlist - newser.com
Aurinia Pharmaceuticals stock hits 52-week high at 13.45 USD - Investing.com
How high can Aurinia Pharmaceuticals Inc. stock goMarket Growth Summary & AI Driven Stock Price Forecasts - newser.com
Analyzing net buyer seller activity in Aurinia Pharmaceuticals Inc.2025 Retail Activity & Reliable Volume Spike Trade Alerts - newser.com
Will Aurinia Pharmaceuticals Inc. price bounce be sustainableWeekly Trend Summary & Entry Point Confirmation Signals - newser.com
Is Aurinia Pharmaceuticals Inc a good long term investmentConsumer Goods Stocks & Build Wealth With Strategy - Early Times
Strs Ohio Buys New Shares in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
Aurinia Pharmaceuticals Hits New 52-Week High of $13.44, Up 142% - Markets Mojo
Acropolis Investment Management LLC Invests $242,000 in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
Aurinia Pharmaceuticals stock hits 52-week high at 13.12 USD By Investing.com - Investing.com Nigeria
Aurinia Pharmaceuticals Hits New 52-Week High of $13.05, Up 140.74% - Markets Mojo
Aurinia Pharmaceuticals stock hits 52-week high at 13.12 USD - Investing.com India
Aurinia Pharmaceuticals (NASDAQ:AUPH) Sets New 1-Year HighHere's What Happened - MarketBeat
Aurinia Pharmaceuticals stock climbs on insider buying - MSN
Does Aurinia Pharmaceuticals Inc. show high probability of reboundJuly 2025 Movers & AI Based Buy and Sell Signals - newser.com
Will Aurinia Pharmaceuticals Inc. outperform the marketGlobal Markets & Stepwise Trade Execution Plans - newser.com
Does Aurinia Pharmaceuticals Inc. fit your quant trading modelPortfolio Performance Summary & Short-Term High Return Ideas - newser.com
Aurinia’s Big Bet On Lupus Nephritis Is Paying Off - Finimize
26,155 Shares in Aurinia Pharmaceuticals Inc $AUPH Bought by City Center Advisors LLC - MarketBeat
Aug Sentiment: Why is Aurinia Pharmaceuticals Inc. stock going downMarket Performance Report & Weekly Top Performers Watchlists - خودرو بانک
Activity Recap: Is Aurinia Pharmaceuticals Inc stock a smart retirement pick2025 Price Momentum & Entry and Exit Point Strategies - خودرو بانک
Nephrotic Syndrome Market Analysis: Epidemiology Insights, Therapies, Companies, DelveInsight | GlaxoSmithKline, Goldfinch Bio, Inc., Travere Therapeutics, Inc., Aurinia Pharmaceuticals, Bristol-Myers - Barchart.com
Is now a turning point for Aurinia Pharmaceuticals Inc.Rate Hike & Verified Chart Pattern Signals - newser.com
Long term hold vs stop loss in Aurinia Pharmaceuticals Inc.Day Trade & Weekly Return Optimization Plans - newser.com
Aug Closing: Can Aurinia Pharmaceuticals Inc grow without external fundingShare Buyback & Expert Verified Stock Movement Alerts - khodrobank.com
Will a bounce in Aurinia Pharmaceuticals Inc. offer an exit2025 Market Sentiment & Weekly Watchlist for Hot Stocks - newser.com
What is the target price for Aurinia Pharmaceuticals Inc. stock2025 Winners & Losers & Technical Pattern Alert System - khodrobank.com
2.36%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):